There are a couple of differences from the normal OTC situation to be aware of, IMO. Specially, DSNY does not need financing and already has its own promotion set up with regular businesses - which they (heaven forbid !) are putting on hold until DSNY is ready to go - around September 1.
This is quite different from a lot of small companies on the OTC market which are trying to raise stock price and/or gain financing for operations. For those situations, the company is prone to working with "investor relation" firms paid via stock to promote the company for a month. As a part of the deal, the "IR firm" gets stock which it can dump - crushing the price. Likewise, if the small company works with a toxic financing firm, the toxic financier also gets shares which it can dump. DSNY is in neither of these situations.
Hope I'm right about this...